Xilio Therapeutics, Inc. (XLO)
NASDAQ · Healthcare
Xilio Therapeutics, Inc. Net Income 2024–2025
Xilio Therapeutics, Inc. annual/quarterly net income history and growth rate from 2024 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Xilio Therapeutics, Inc. net income for the quarter ending March 31, 2026 was -9.5 M, a 28.16% decrease year-over-year.
- Xilio Therapeutics, Inc. net income for the twelve months ending March 31, 2026 was -54.9 M.
- Xilio Therapeutics, Inc. annual net income for 2025 was -35.0 M, a 39.84% decrease from 2024.
- Xilio Therapeutics, Inc. annual net income for 2024 was -58.2 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Xilio Therapeutics, Inc. Net Income — FAQ
Xilio Therapeutics, Inc. (XLO) net income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Xilio Therapeutics, Inc.'s net income?
Xilio Therapeutics, Inc. (XLO) reported net income of -$35M for fiscal 2025.
Where can I see XLO's net income history?
The chart and table above show Xilio Therapeutics, Inc.'s net income by year and by quarter, including the growth rate.